Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

sergliflozin

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Abstract Background With the growing prevalence of obesity and its associated metabolic consequences, new strategies for safe and… Expand
Is this relevant?
Review
2017
Review
2017
Abstract 1. Several sodium-glucose cotransporter-2 (SGLT-2) inhibitors are in clinical use for the management of type 2 diabetes… Expand
Is this relevant?
2013
2013
Despite availability of a number of oral antidiabetics, a sizeable population of diabetics remains uncontrolled. Thus there is… Expand
Is this relevant?
Review
2012
Review
2012
The incidence of type 2 diabetes mellitus is increasing worldwide. The existing therapeutic classes of antidiabetic drugs are not… Expand
Is this relevant?
2012
2012
C-Aryl 5a-carba-β-d-glucopyranose derivatives were synthesized and evaluated for inhibition activity against hSGLT1 and hSGLT2… Expand
Is this relevant?
2011
2011
5a-Carba-β-D-glucopyranose derivatives were synthesized and identified as novel SGLT2-selective inhibitors. These inhibitors… Expand
Is this relevant?
Review
2011
Review
2011
  • Masayuki Isaji
  • Kidney international. Supplement
  • 2011
  • Corpus ID: 205184411
The physiological and pathological handling of glucose via sodium-glucose cotransporter-2 (SGLT2) in the kidneys has been… Expand
  • figure 1
  • table 1
Is this relevant?
Review
2009
Review
2009
The kidneys play a major role in the regulation of glucose in humans, reabsorbing 99% of the plasma glucose that filters through… Expand
Is this relevant?
Review
2008
Review
2008
OBJECTIVE To review the renal handling of glucose and the role of inhibition of a sodium-glucose transporter (SGLT2) in the… Expand
Is this relevant?